{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:05:07Z","timestamp":1785423907591,"version":"3.56.0"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":455,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Abnormalities in specific echocardiographic parameters and cardiac biomarkers have been reported among individuals with diabetes. However, a comprehensive characterization of diabetic cardiomyopathy (DbCM), a subclinical stage of myocardial abnormalities that precede the development of clinical heart failure (HF), is lacking. In this study, we developed and validated a machine learning-based clustering approach to identify the high-risk DbCM phenotype based on echocardiographic and cardiac biomarker parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Among individuals with diabetes from the Atherosclerosis Risk in Communities (ARIC) cohort who were free of cardiovascular disease and other potential aetiologies of cardiomyopathy (training, n\u2009=\u20091199), unsupervised hierarchical clustering was performed using echocardiographic parameters and cardiac biomarkers of neurohormonal stress and chronic myocardial injury (total 25 variables). The high-risk DbCM phenotype was identified based on the incidence of HF on follow-up. A deep neural network (DeepNN) classifier was developed to predict DbCM in the ARIC training cohort and validated in an external community-based cohort (Cardiovascular Health Study [CHS]; n\u2009=\u2009802) and an electronic health record (EHR) cohort (n\u2009=\u20095071). Clustering identified three phenogroups in the derivation cohort. Phenogroup-3 (n\u2009=\u2009324, 27% of the cohort) had significantly higher 5-year HF incidence than other phenogroups (12.1% vs. 4.6% [phenogroup 2] vs. 3.1% [phenogroup 1]) and was identified as the high-risk DbCM phenotype. The key echocardiographic predictors of high-risk DbCM phenotype were higher NT-proBNP levels, increased left ventricular mass and left atrial size, and worse diastolic function. In the CHS and University of Texas (UT) Southwestern EHR validation cohorts, the DeepNN classifier identified 16% and 29% of participants with DbCM, respectively. Participants with (vs. without) high-risk DbCM phenotype in the external validation cohorts had a significantly higher incidence of HF (hazard ratio [95% confidence interval] 1.61 [1.18\u20132.19] in CHS and 1.34 [1.08\u20131.65] in the UT Southwestern EHR cohort).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Machine learning-based techniques may identify 16% to 29% of individuals with diabetes as having a high-risk DbCM phenotype who may benefit from more aggressive implementation of HF preventive strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.3443","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T10:57:53Z","timestamp":1725620273000},"page":"2183-2192","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development and Validation of a Machine Learning-Based Approach to Identify High-Risk Diabetic Cardiomyopathy Phenotype"],"prefix":"10.1093","volume":"26","author":[{"given":"Matthew W.","family":"Segar","sequence":"first","affiliation":[{"name":"Department of Cardiology, Texas Heart Institute , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shariq","family":"Usman","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center , Dallas, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kershaw V.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahzeb","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Duke University , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Mississippi Medical Center , Jackson, MS ,","place":["USA"]},{"name":"Baylor Scott and White Research Institute, Baylor Scott and White Health System , Dallas, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshman","family":"Manjunath","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Baylor Scott & White Medical Center , Dallas, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.P.","family":"Lam","sequence":"additional","affiliation":[{"name":"National Heart Centre Singapore and Duke\u2013National University of Singapore , Singapore ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Verma","sequence":"additional","affiliation":[{"name":"St Michael's Hospital, University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DuWayne","family":"Willett","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center , Dallas, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kao","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, University of Colorado School of Medicine , Denver, CO ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Harvard Medical School, Baim Institute for Clinical Research , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambarish","family":"Pandey","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center , Dallas, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"2026010913035715600_ejhf3443-bib-0001","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.22190","article-title":"Temporal trends in heart failure incidence among Medicare beneficiaries across risk factor strata, 2011 to 2016","volume":"3","author":"Khera","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026010913035715600_ejhf3443-bib-0002","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.122.063374","article-title":"Twenty years of cardiovascular complications and risk factors in patients with type 2 diabetes: A nationwide Swedish cohort study","volume":"147","author":"Sattar","year":"2023","journal-title":"Circulation"},{"key":"2026010913035715600_ejhf3443-bib-0003","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med"},{"key":"2026010913035715600_ejhf3443-bib-0004","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2337\/dci22-0014","article-title":"Heart failure: An underappreciated complication of diabetes. A consensus report of the American Diabetes Association","volume":"45","author":"Pop-Busui","year":"2022","journal-title":"Diabetes Care"},{"key":"2026010913035715600_ejhf3443-bib-0005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jacc.2017.11.019","article-title":"Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy","volume":"71","author":"Marwick","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026010913035715600_ejhf3443-bib-0006","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: An update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"2026010913035715600_ejhf3443-bib-0007","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: A two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Seferovic","year":"2015","journal-title":"Eur Heart J"},{"key":"2026010913035715600_ejhf3443-bib-0008","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jchf.2020.10.013","article-title":"Biomarker-based risk prediction of incident heart failure in pre-diabetes and diabetes","volume":"9","author":"Pandey","year":"2021","journal-title":"JACC Heart Fail"},{"key":"2026010913035715600_ejhf3443-bib-0009","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2011.1201","article-title":"Progression of left ventricular diastolic dysfunction and risk of heart failure","volume":"306","author":"Kane","year":"2011","journal-title":"JAMA"},{"key":"2026010913035715600_ejhf3443-bib-0010","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.amjmed.2008.03.046","article-title":"Diabetic cardiomyopathy: Insights into pathogenesis, diagnostic challenges, and therapeutic options","volume":"121","author":"Aneja","year":"2008","journal-title":"Am J Med"},{"key":"2026010913035715600_ejhf3443-bib-0011","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13098-023-00998-y","article-title":"Potential clinical biomarkers and perspectives in diabetic cardiomyopathy","volume":"15","author":"Deng","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"2026010913035715600_ejhf3443-bib-0012","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12933-017-0506-x","article-title":"Diagnostic approaches for diabetic cardiomyopathy","volume":"16","author":"Lorenzo-Almor\u00f3s","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"2026010913035715600_ejhf3443-bib-0013","doi-asserted-by":"crossref","first-page":"L86","DOI":"10.1093\/eurheartj\/suaa142","article-title":"New and old echographic parameters in heart failure","volume":"22","author":"La Canna","year":"2020","journal-title":"Eur Heart J Suppl"},{"key":"2026010913035715600_ejhf3443-bib-0014","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.jacc.2017.03.571","article-title":"Artificial intelligence in precision cardiovascular medicine","volume":"69","author":"Krittanawong","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026010913035715600_ejhf3443-bib-0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ejhf.1621","article-title":"Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis","volume":"22","author":"Segar","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026010913035715600_ejhf3443-bib-0016","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00125-021-05426-2","article-title":"Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes","volume":"64","author":"Segar","year":"2021","journal-title":"Diabetologia"},{"key":"2026010913035715600_ejhf3443-bib-0017","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jacc.2017.07.792","article-title":"Clinical implications of echocardiographic phenotypes of patients with diabetes mellitus","volume":"70","author":"Ernande","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026010913035715600_ejhf3443-bib-0018","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: A data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026010913035715600_ejhf3443-bib-0019","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The Atherosclerosis Risk in Communities (ARIC) study: Design and objectives","volume":"129","year":"1989","journal-title":"Am J Epidemiol"},{"key":"2026010913035715600_ejhf3443-bib-0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/1047-2797(91)90005-W","article-title":"The Cardiovascular Health Study: Design and rationale","volume":"1","author":"Fried","year":"1991","journal-title":"Ann Epidemiol"},{"key":"2026010913035715600_ejhf3443-bib-0021","article-title":"Prevalence and predictors of subclinical cardiomyopathy in patients with type 2 diabetes in a health system","author":"Nagori","year":"2023","journal-title":"J Diabetes Sci Technol"},{"key":"2026010913035715600_ejhf3443-bib-0022","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamacardio.2022.1781","article-title":"A simple score to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction","volume":"7","author":"Davies","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2026010913035715600_ejhf3443-bib-0023","first-page":"e558","article-title":"2020 AHA\/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"2026010913035715600_ejhf3443-bib-0024","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026010913035715600_ejhf3443-bib-0025","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1373\/clinchem.2013.203638","article-title":"Troponin T and N-terminal pro-B-type natriuretic peptide: A biomarker approach to predict heart failure risk \u2013 The Atherosclerosis Risk in Communities study","volume":"59","author":"Nambi","year":"2013","journal-title":"Clin Chem"},{"key":"2026010913035715600_ejhf3443-bib-0026","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.109.873265","article-title":"N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: The Cardiovascular Health Study","volume":"120","author":"Patton","year":"2009","journal-title":"Circulation"},{"key":"2026010913035715600_ejhf3443-bib-0027","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/CIRCIMAGING.113.000736","article-title":"Rationale and design of a multicenter echocardiographic study to assess the relationship between cardiac structure and function and heart failure risk in a biracial cohort of community-dwelling elderly persons: The Atherosclerosis Risk in Communities study","volume":"7","author":"Shah","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026010913035715600_ejhf3443-bib-0028","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0894-7317(14)80105-3","article-title":"Echocardiographic design of a multicenter investigation of free-living elderly subjects: The Cardiovascular Health Study","volume":"5","author":"Gardin","year":"1992","journal-title":"J Am Soc Echocardiogr"},{"key":"2026010913035715600_ejhf3443-bib-0029","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings","volume":"57","author":"Devereux","year":"1986","journal-title":"Am J Cardiol"},{"key":"2026010913035715600_ejhf3443-bib-0030","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.amjcard.2007.11.061","article-title":"Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study)","volume":"101","author":"Loehr","year":"2008","journal-title":"Am J Cardiol"},{"key":"2026010913035715600_ejhf3443-bib-0031","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/CIRCHEARTFAILURE.111.963199","article-title":"Classification of heart failure in the Atherosclerosis Risk in Communities (ARIC) study: A comparison of diagnostic criteria","volume":"5","author":"Rosamond","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2026010913035715600_ejhf3443-bib-0032","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/1047-2797(94)00093-9","article-title":"Surveillance and ascertainment of cardiovascular events: The Cardiovascular Health Study","volume":"5","author":"Ives","year":"1995","journal-title":"Ann Epidemiol"},{"key":"2026010913035715600_ejhf3443-bib-0033","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024094","article-title":"Validation of the WATCH-DM and TRS-HFDM risk scores to predict the risk of incident hospitalization for heart failure among adults with type 2 diabetes: A multicohort analysis","volume":"11","author":"Segar","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026010913035715600_ejhf3443-bib-0034","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/1467-9868.00293","article-title":"Estimating the number of clusters in a data set via the gap statistic","volume":"63","author":"Tibshirani","year":"2002","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"2026010913035715600_ejhf3443-bib-0035","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.jcmg.2021.04.010","article-title":"Deep-learning models for the echocardiographic assessment of diastolic dysfunction","volume":"14","author":"Pandey","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026010913035715600_ejhf3443-bib-0036","volume-title":"Processing of missing data by neural networks","author":"Smieja"},{"key":"2026010913035715600_ejhf3443-bib-0037","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2021.08.020","article-title":"Prevalence and prognostic implications of diabetes with cardiomyopathy in community-dwelling adults","volume":"78","author":"Segar","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026010913035715600_ejhf3443-bib-0038","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022308","article-title":"Cardiac structure and function and diabetes-related risk of death or heart failure in older adults","volume":"11","author":"Inciardi","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026010913035715600_ejhf3443-bib-0039","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"2026010913035715600_ejhf3443-bib-0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2026010913035715600_ejhf3443-bib-0041","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jacc.2018.12.054","article-title":"Artificial intelligence in cardiovascular imaging: JACC state-of-the-art review","volume":"73","author":"Dey","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026010913035715600_ejhf3443-bib-0042","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1161\/CIRCULATIONAHA.120.053134","article-title":"Development and validation of machine learning-based race-specific models to predict 10-year risk of heart failure: A multicohort analysis","volume":"143","author":"Segar","year":"2021","journal-title":"Circulation"},{"key":"2026010913035715600_ejhf3443-bib-0043","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/ejhf.2723","article-title":"Optimal cardiometabolic health and risk of heart failure in type 2 diabetes: An analysis from the look AHEAD trial","volume":"24","author":"Patel","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026010913035715600_ejhf3443-bib-0044","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2337\/dc15-1760","article-title":"Natriuretic peptide and high-sensitivity troponin for cardiovascular risk prediction in diabetes: The Atherosclerosis Risk in Communities (ARIC) study","volume":"39","author":"Gori","year":"2016","journal-title":"Diabetes Care"},{"key":"2026010913035715600_ejhf3443-bib-0045","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/eurheartj\/ehs188","article-title":"Left atrial structure and function and clinical outcomes in the general population","volume":"34","author":"Gupta","year":"2013","journal-title":"Eur Heart J"},{"key":"2026010913035715600_ejhf3443-bib-0046","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jacc.2013.05.069","article-title":"PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): A prospective randomized controlled trial","volume":"62","author":"Huelsmann","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026010913035715600_ejhf3443-bib-0047","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: A meta-analysis","volume":"6","author":"McGuire","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2026010913035715600_ejhf3443-bib-0048","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0735-1097(23)01269-X","article-title":"Effect of canagliflozin on heart failure hospitalization in diabetes according to baseline heart failure risk","volume":"11","author":"Khan","year":"2023","journal-title":"JACC: Heart Fail"},{"key":"2026010913035715600_ejhf3443-bib-0049","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCULATIONAHA.119.042685","article-title":"Heart failure risk stratification and efficacy of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes mellitus","volume":"140","author":"Berg","year":"2019","journal-title":"Circulation"},{"key":"2026010913035715600_ejhf3443-bib-0050","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.2337\/dc21-1170","article-title":"A biomarker-based score for risk of hospitalization for heart failure in patients with diabetes","volume":"44","author":"Berg","year":"2021","journal-title":"Diabetes Care"},{"key":"2026010913035715600_ejhf3443-bib-0051","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023811","article-title":"National trends in use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists by cardiologists and other specialties, 2015 to 2020","volume":"11","author":"Adhikari","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026010913035715600_ejhf3443-bib-0052","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S2213-8587(23)00128-6","article-title":"Predicting and preventing heart failure in type 2 diabetes","volume":"11","author":"Pandey","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026010913035715600_ejhf3443-bib-0053","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ejhf.3176","article-title":"Association of diabetes-specific heart failure risk score with presence of subclinical cardiomyopathy among individuals with diabetes: A prospective study","volume":"26","author":"Chunawala","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026010913035715600_ejhf3443-bib-0054","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jacc.2024.03.380","article-title":"Randomized trial of a selective aldose reductase inhibitor in patients with diabetic cardiomyopathy","volume":"84","author":"Januzzi","year":"2024","journal-title":"J Am Coll Cardiol"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/26\/10\/2183\/65510900\/eurjhf_26_10_2183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/26\/10\/2183\/65510900\/eurjhf_26_10_2183.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:04:36Z","timestamp":1767981876000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/26\/10\/2183\/8322673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":54,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,9,6]]},"published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.3443","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"2024-05-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}